The aim of this study was to investigate the association of cannabinoid receptor 1 (CNR1) 4895 C/T gene polymorphism with obesity and obesity-related cardiovascular disease (CVD) risk factors in Japanese. Method: This study included 1,452 Japanese (678 men and 774 women, aged 25 to 74) from rural communities in Shimane Prefecture, Japan. Results: The frequency of the C minor allele of CNR1 4895 C/T polymorphism was 47%. In men, the CC genotype carriers showed significantly greater body mass index (BMI) and waist circumference (WC) values than T allele carriers, even after adjusting for age and medications for hypertension, dyslipidemia and type 2 diabetes. The frequency of obesity (BMI ≥ 25 kg/m 2 ) in CC genotype carriers was significantly greater than in T allele carriers (31.8% vs 21.5%), but the frequency of central obesity (WC ≥ 85 for men and WC ≥ 90 cm for women) was not significant by CNR1 4895 C/T genotype. CC genotype carriers of CNR1 4895 C/T showed, in logistic regression analysis, significantly greater odds for obesity than T allele carriers, even after adjustment for age and the abovementioned medications. Systolic blood pressure (SBP) values were also significantly different between the CC genotype and T allele carriers after controlling for age, medications for hypertension, dyslipidemia, and type 2 diabetes, and BMI or WC. Conclusion: This study supports the association of CNR1 4895 C/T with interindividual differences in obesity in men. 
Introduction
The endocannabinoid system (ECS) has been increasingly associated with various cardiovascular disease (CVD) risk factors such as obesity, type 2 diabetes, hypertension and dyslipidemia 1, 2) . It has now been well demonstrated that activation of the ECS facilitates energy intake and storage. Most ECS roles have been elucidated by blockade of the CNR1 receptor, the most abundantly expressed ECS receptor 3) . The CNR1 gene, located on 6q14-q15, harbors multi-ple single nucleotide polymorphisms (SNP) among which the 4895 C/T (rs806368) gene polymorphism in the 3'UTR region of exon 4 of CNR1 is reportedly a tagged SNP for the Japanese population 4) . As such, this polymorphism can be used to assess the effects of this gene in this population. There have been discrepant reports of the CNR1 4895 C/T (rs806368) gene variant's association with obesity in Caucasians [5] [6] [7] ; however, such a possible association has yet to be shown in a Japanese population, and studies assessing the relationship of this polymorphism with other CVD risk factors are also scarce 8) . Japanese adults reportedly have a higher percentage of body fat and/or greater visceral fat accumulation for the relatively same body mass index (BMI) than other ethnic groups, such as Caucasians 9, 10) . Thus, to measure obesity in the Japanese population, HDL-cholesterol (HDL-C), triglycerides (TG) and LDL-cholesterol (LDL-C) were measured by enzymatic methods 12) , and glycated hemoglobin (HbA1c JDS) by high-performance liquid chromatography according to the method of the Japanese Diabetes Society (JDS).
DNA Analysis
Genomic DNA was prepared from leukocytes using a DNA Extractor WB Kit (Wako Pure Chemical, Osaka, Japan). CNR1 4895 C/T (rs806368) was detected using a TaqMan genotyping assay (Assay ID C_8943804_10; Applied Biosystems, Foster City, CA). SNP genotyping was performed as required by the Applied Biosystems protocol for allelic discrimination using an 7900HT Fast Real Time PCR system.
Statistical Analysis
TG and HbA1c were log transformed before performing statistical analysis. Men and women were studied separately. Analyses were conducted comparing T allele carriers to CC genotype carriers, due to the dominant effect of T allele (Supplemental Table 1 ). Student's t -test was used to assess the differences in parameters by genotype subgroups. Significant associations were further analyzed using analysis of co-variance (ANCOVA) to adjust for the effects of confounding factors. Mean values were adjusted for age (Model 1); for age and prescribed medications for type 2 diabetes, hyperlipidemia and hypertension ("medications") (Model 2); for age, BMI and medications (Model 3); and for age, WC and medications (Model 4). The χ 2 test was used to test for Hardy Weinberg equilibrium and to compare the frequency of obesity, central obesity, and prescribed medications among the genotype subgroups. Odds ratio (OR) for obesity and central obesity status adjusted for age (dichotomized with a cut-off point of ≥ 55 years for men and ≥ 65 years for women) and medications was assessed by logistic regression. Cut-off points of BMI ≥ 25 kg/m 2 and WC ≥ 85 for men and WC ≥ 90 cm for women were used to define obesity and the central obesity status, respectively 13, 14) . A two-sided p-value of less than 0.05 was used to assess significance. Data were analyzed with SPSS statistical analysis software (Version 13; SPSS Inc., Chicago, IL).
Results
The frequency of the C minor allele of CNR1 4895 C/T polymorphism was 47%, with the frequency of TT wild-type, TC heterozygote and CC homozygote carriers being 27.9% (405/1452), 51.0% (740/1452) and 21.1% (307/1452), respectively. The it appears that the best method should incorporate both BMI and waist circumference (WC), as the latter is more suitable for detecting metabolically obese, but lean subjects 11) . Considering the paucity of information on this gene variant, and more importantly, the critical role ECS may play in certain CVD risk factors, it appears crucial to investigate the effects of this gene polymorphism on CVD risk factors in Japanese. We hypothesized that the CNR1 4895 C/T gene variant is associated with CVD risk factors, namely obesity, type 2 diabetes, hypertension and dyslipidemia, in Japanese.
Method

Subjects
A total of 1,784 Japanese adults were recruited during health examinations in three rural communities in Shimane Prefecture, Japan: Kakeya (806 subjects in 2006) and Mitoya (383 subjects in 2007) in Unnan City, and Sada (595 subjects in 2005) in Izumo City. The 3 populations presented with similar characteristics and were therefore studied as a group. Information on each participant's lifestyle and health status was obtained through an interview, including questions regarding prescription medicines for diseases such as diabetes, dyslipidemia, hypertension or CVD. Subjects under prescribed medications for hypertension (n = 329) and/or type 2 diabetes (n = 60) and/or hyperlipidemia (n= 154) were retained in this study, as their exclusion would have significantly reduced the sample size and study power. A total of 332 persons 75 years of age and above were rejected as subjects of this study. The remaining 1452 subjects (678 men, age 56.8±13.4 years and 774 women, age 60.9±11.9 years) were eligible for the purpose of this study. The Ethics Committee of Shimane University School of Medicine approved all study protocols, and all subjects gave written informed consent.
Anthropometric Measurements
Each subject's body weight with very light clothing was measured to an accuracy of ±0.2 kg, and height to an accuracy of ±0.5 cm using a height bar. BMI was computed as weight (kg) divided by squared height (m 2 ). WC was measured with a flexible tape midway between the iliac crest and the lowest rib margin at minimum respiration. Blood pressure was measured twice using a standard mercury sphygmomanometer while the subject was seated.
Laboratory Measurements
Venous blood was collected after overnight fasting.
and 43.9% of CC genotype carriers were centrally obese, based on WC (p = 0.148). CC genotype carriers also showed significantly greater systolic blood pressure (SBP) and diastolic blood pressure (DBP) than T allele carriers (p = 0.005 and p = 0.049, respectively). No significant differences between CNR1 4895 C/T genotype groups were found in women. Adjustment for confounding factors (Table 2) showed that the association with BMI and WC was maintained after further adjustment for age (p＜0.001 and p = 0.016, respectively), and the results were similar after additional adjustment for medications (p＜ genotype distribution was in Hardy-Weinberg equilibrium: χ 2 = 0.83 (p＞0.05). The CNR1 4895 C/T genotype groups showed no differences regarding their gender distribution and age.
In men, the CC genotype carriers showed significantly greater BMI and WC values than T allele carriers (p＜0.001 and p = 0.016, respectively) ( Table 1) . In line with these findings, the frequency of obesity based on BMI was greater for CC genotype carriers than T allele carriers, at 31.8% and 21.5%, respectively (p = 0.010). In contrast, no association was found with central obesity: 37.4% of T allele carriers 
Discussion
This study demonstrated that Japanese men carriers of the CC genotype of CNR1 4895 C/T show greater BMI and WC values, and are more likely to be obese than T allele carriers. The mechanism of this association may be explainable by the effects of the ECS on food ingestion regulation, and also on lipid and glucose metabolism in various peripheral tissues, notably the liver and adipose tissue 15) . The ECS acting via CNR1 has been demonstrated to be involved in brain areas associated with appetite control, including the hypothalamus, limbic forebrain and amygdala, resulting in a hunger-induced increase in food intake. CNR1 stimulation has also been shown to increase de novo hepatic lipogenesis through activation of the fatty acid biosynthetic pathway, to enhance energy storage in adipose tissue, and to reduce energy expenditure 15, 16) . Strikingly, these associations have been found only in men. This may be explained by gender-specific effects of the ECS in certain physiological and behavioral functions such as food intake and energy balance, which have been shown to be more evident in men than women 17) . Men are known to be more sensitive Finally, the odds ratios for obesity and central obesity were investigated between CC genotype carriers and T allele carriers of CNR1 4895 C/T polymorphism (Fig. 1) . In men, the CC genotype carriers were more likely to be obese than the T allele carriers even after adjustment for age and medications (OR (CI95%): 1.7 (1.1-2.6); p = 0.010). There were no significant differences in the odds ratios of central obesity in men, or in the odds ratios of obesity and central obesity in women. at least in part be due to obesity, although the rationale behind this association is yet to be determined. A stressful situation such as obesity can activate the ECS, which was shown in mice to induce a certain degree of lower blood pressure through enhanced blood vessel dilatation 21, 22) . In contrast, it was reported that the blockade of CNR1 attenuated renal sympathico-excitation, while its expression elicited renal sympathicoexcitation and raised blood pressure 23) . It appears the ECS may be pro-hypertensive due to its association with higher central obesity risk and renal sympathicoexcitation; however, it might also produce a hypertension-buffering effect by the effects on blood vessels. Further studies are needed for more precise analysis.
This study has certain limitations. The cross-sectional design of this study prevents it from inferring any causal relationship. Additionally, the non-inclusion of potential confounding factors such as diet composition and physical activity, as well as the ethnic specificity, requires cautious interpretation of these findings. 
Funding
This study was supported in part by Grants-in-Aid to the hyperphagic and hypophagic effects of CNR1 agonists and antagonists. An experimental study also demonstrated that male but not female CNR1 knockout mice had diminished nocturnal food intake and average daily body weight as compared to their wild type littermates. In addition, gonadectomized guinea pigs showed considerably more robust stimulation of intake in males than in females 18) . In this study, while CNR1 4895 C/T polymorphism showed a significant association with WC, no significant association was found with central obesity based on WC. This difference may be due to the age difference in WC cut-off values for the definition of central obesity. In fact, it has been demonstrated that, when comparing the oldest subjects to the youngest, there is a greater amount of visceral fat in the older aged group regardless of BMI 19) ; further, the sensitivity of detecting subjects with metabolic syndrome using the same cut-off value for younger (less than 40 years old) and older groups was lower for the younger group 20) . A lower cut-off value might therefore be needed for younger subjects when defining central obesity. Given that we included adults from 25 to 74 years of age in this study, it is plausible that some centrally obese young subjects may have been misclassified.
While this study reports an association between CNR1 4895 C/T and SBP and DBP, such a relationship was weakened, particularly for DBP, by adjusting for BMI or WC, suggesting that any association may Odds ratio was calculated using logistic regression analysis adjusted for age, type 2 diabetes, dyslipidemia and hypertension. One-way ANOVA was used to assess the differences in metabolic parameters by genotype subgroups. χ 2 test was used to compare frequency of obesity, central obesity, type 2 diabetes, hypertension and dyslipidemia between genotype subgroups. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglyceride; HbA1c: glycated hemoglobin 1, obesity was defined as BMI ≥ 25 kg/m 2 ; 2, central obesity was defined WC ≥ 85 for men and WC ≥ 90 cm for women. 3, frequency of subjects using prescribed medications for hypertension, dyslipidemia or type 2 diabetes.
